179 related articles for article (PubMed ID: 28689589)
1. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
Pozzato G; Mazzaro C; Gattei V
Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
4. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and lymphoma.
Paydas S
Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
[TBL] [Abstract][Full Text] [Related]
6. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
Torres HA; Mahale P
Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
[TBL] [Abstract][Full Text] [Related]
7. Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi.
Merli M; Rattotti S; Spina M; Re F; Motta M; Piazza F; Orsucci L; Ferreri AJM; Perbellini O; Dodero A; Vallisa D; Pulsoni A; Santoro A; Sacchi P; Zuccaro V; Chimienti E; Russo F; Visco C; Zignego AL; Marcheselli L; Passamonti F; Luminari S; Paulli M; Bruno R; Arcaini L;
J Clin Oncol; 2022 Dec; 40(35):4060-4070. PubMed ID: 35714311
[TBL] [Abstract][Full Text] [Related]
8. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
[TBL] [Abstract][Full Text] [Related]
9. From hepatitis C virus infection to B-cell lymphoma.
Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Pozzato G; Mazzaro C; Gattei V
Minerva Med; 2021 Apr; 112(2):215-227. PubMed ID: 33263375
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
[TBL] [Abstract][Full Text] [Related]
13. Expert opinion on managing chronic HCV in patients with non-Hodgkin lymphoma and other extrahepatic malignancies.
Ferri C; Feld JJ; Bondin M; Cacoub P
Antivir Ther; 2018; 23(Suppl 2):23-33. PubMed ID: 30451149
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus - Associated marginal zone lymphoma.
Armand M; Besson C; Hermine O; Davi F
Best Pract Res Clin Haematol; 2017; 30(1-2):41-49. PubMed ID: 28288715
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M; Carli G; Arcaini L; Visco C
World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
[TBL] [Abstract][Full Text] [Related]
16. Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.
Sica A; Spada A; Sagnelli C; Verolino P; Mazzocca A; Sagnelli E; Colella G; Guastafierro S; Marrone A
Infez Med; 2021 Jun; 29(2):277-279. PubMed ID: 34061795
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?
Khoury T; Chen S; Adar T; Jacob EO; Mizrahi M
World J Gastroenterol; 2014 Nov; 20(43):16197-202. PubMed ID: 25473174
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapy.
Mazzaro C; Dal Maso L; Visentini M; Ermacora A; Andreone P; Gattei V; Pozzato G
Hematol Oncol; 2021 Oct; 39(4):439-447. PubMed ID: 34477233
[TBL] [Abstract][Full Text] [Related]
19. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
20. HCV infection and non-Hodgkin lymphomas: an evolving story.
Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L
Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]